Alpelisib Challenge Test (ACT)

Clinical trial NCT07778524 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07778524
Sponsor: Columbia University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Insulin Resistance Type 2 Diabetes Obesity & Overweight Healthy Adult Participants

Start date: 2026-09-01
Primary completion: 2028-08-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.